Ruilin Cai 37th Lorne Cancer Conference 2025

Abstracts this author is presenting:

• Exploring the therapeutic potential of ACHM-025, a novel AKR1C3-activated prodrug, in preclinical models of paediatric T-cell acute lymphoblastic leukaemia — Poster Session I and Welcome Reception